|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
WO1998011244A2
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
CA2319089A1
(en)
|
1998-04-09 |
1999-10-21 |
Genset S.A. |
5' ests and encoded human proteins
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
WO1999061601A2
(en)
|
1998-05-28 |
1999-12-02 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav5 vector and uses thereof
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
ATE362542T1
(de)
|
1998-11-05 |
2007-06-15 |
Univ Pennsylvania |
Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
|
|
US20020077470A1
(en)
|
1999-04-26 |
2002-06-20 |
Walker Michael G. |
Cardiac muscle-associated genes
|
|
JP2004502426A
(ja)
*
|
2000-07-05 |
2004-01-29 |
トランジェーヌ、ソシエテ、アノニム |
平滑筋の発現を制御するキメラプロモーター
|
|
WO2002053703A2
(en)
|
2001-01-05 |
2002-07-11 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
MX359371B
(es)
|
2001-11-13 |
2018-09-25 |
Univ Pennsylvania |
Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo.
|
|
DK2573170T3
(en)
|
2001-12-17 |
2018-04-09 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 9, vectors containing them, and their use
|
|
PT1453547T
(pt)
|
2001-12-17 |
2016-12-28 |
Univ Pennsylvania |
Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
|
|
SI1633772T1
(sl)
|
2003-06-19 |
2016-06-30 |
Genzyme Corporation |
AAV virioni z zmanjšano imunoreaktivnostjo in uporaba za ta namen
|
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
EP2345731B1
(en)
|
2003-09-30 |
2015-10-21 |
The Trustees of the University of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
|
|
JP5136766B2
(ja)
|
2004-12-15 |
2013-02-06 |
ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
キメラベクター
|
|
ES2714007T3
(es)
|
2007-04-09 |
2019-05-24 |
Univ Florida |
Composiciones de vectores rAAV que tienen proteínas de la cápside modificadas en tirosina y métodos para su uso
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
WO2009137006A2
(en)
|
2008-04-30 |
2009-11-12 |
The University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
WO2010093784A2
(en)
|
2009-02-11 |
2010-08-19 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
WO2011051450A1
(en)
|
2009-10-29 |
2011-05-05 |
Vib Vzw |
Cardiac-specific nucleic acid regulatory elements and methods and use thereof
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
CN105755044A
(zh)
|
2011-04-22 |
2016-07-13 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体及其使用方法
|
|
US9434928B2
(en)
|
2011-11-23 |
2016-09-06 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
EP3747457A3
(en)
*
|
2013-01-17 |
2021-03-03 |
Medizinische Hochschule Hannover |
Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
|
|
EP3043866A4
(en)
|
2013-09-12 |
2017-05-17 |
President and Fellows of Harvard College |
Methods for inducing glucose uptake
|
|
US10072251B2
(en)
|
2014-02-19 |
2018-09-11 |
University Of Massachusetts |
Recombinant AAVS having useful transcytosis properties
|
|
EP3113787B1
(en)
|
2014-03-04 |
2019-12-04 |
University of Florida Research Foundation, Inc. |
Improved raav vectors and methods for transduction of photoreceptors and rpe cells
|
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
|
CN107073051B
(zh)
|
2014-10-21 |
2021-08-24 |
马萨诸塞大学 |
重组aav变体及其用途
|
|
KR102423442B1
(ko)
|
2015-12-11 |
2022-07-20 |
캘리포니아 인스티튜트 오브 테크놀로지 |
아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
|
|
JP7406783B2
(ja)
|
2015-12-14 |
2023-12-28 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質
|
|
US10570183B2
(en)
|
2016-04-19 |
2020-02-25 |
The Board Of Regents Of The University Of Texas System |
Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
|
|
US11866462B2
(en)
|
2016-05-04 |
2024-01-09 |
Oregon Health & Science University |
Recombinant adeno-associated viral vectors
|
|
WO2017212019A1
(en)
|
2016-06-09 |
2017-12-14 |
Centre National De La Recherche Scientifique (Cnrs) |
Raav with chemically modified capsid
|
|
WO2018026766A1
(en)
|
2016-08-01 |
2018-02-08 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Compositions and methods for treating cardiac injury
|
|
US11905312B2
(en)
|
2017-02-15 |
2024-02-20 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for gene transfer across the vasculature
|
|
JP7332474B2
(ja)
|
2017-02-24 |
2023-08-23 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
ミオミキサーにより促進される筋細胞融合に関連する組成物および方法
|
|
EP4653536A3
(en)
*
|
2017-03-17 |
2026-02-25 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression
|
|
WO2018222503A1
(en)
|
2017-05-31 |
2018-12-06 |
The Regents Of The University Of California |
Adeno-associated virus with variant capsid and methods of use thereof
|
|
EP3808849A1
(en)
|
2017-08-03 |
2021-04-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
GB2571704A
(en)
*
|
2018-02-22 |
2019-09-11 |
Georg August Univ Gottingen Stiftung Offentlichen Rechts Univer Sitatsmedzin Goettingen |
Prevention or treatment of cardiac arrhytmia and sudden cardiac death
|
|
KR102918544B1
(ko)
*
|
2018-07-12 |
2026-01-27 |
로켓 파마슈티컬스, 리미티드 |
다논병을 치료하기 위한 유전자 요법 벡터
|
|
JP7450945B2
(ja)
*
|
2018-08-30 |
2024-03-18 |
テナヤ セラピューティクス， インコーポレイテッド |
ミオカルディンおよびａｓｃｌ１を用いた心細胞リプログラミング
|
|
KR20220022107A
(ko)
|
2018-12-05 |
2022-02-24 |
아베오나 테라퓨틱스 인코퍼레이티드 |
유전자 전달을 위한 재조합 아데노-연관 바이러스 벡터
|
|
EP3906308A1
(en)
*
|
2018-12-31 |
2021-11-10 |
Research Institute at Nationwide Children's Hospital |
Dux4 rna silencing using rna targeting crispr-cas13b
|
|
AR118465A1
(es)
|
2019-03-21 |
2021-10-06 |
Stridebio Inc |
Vectores de virus adenoasociados recombinantes
|
|
KR102934700B1
(ko)
|
2019-03-28 |
2026-03-09 |
더 제너럴 하스피탈 코포레이션 |
트랜스진 발현을 위한 조작된 아데노-연관 (aav) 벡터
|
|
EP4087489B1
(en)
|
2020-01-08 |
2025-05-14 |
Vitruvia Holdings Inc. |
Methods and computing system for processing ultrasound image to determine health of subdermal tissue
|
|
WO2021163357A2
(en)
*
|
2020-02-13 |
2021-08-19 |
Tenaya Therapeutics, Inc. |
Gene therapy vectors for treating heart disease
|
|
MX2023000318A
(es)
|
2020-07-07 |
2023-02-09 |
Univ Texas |
Vector de virus adenoasociado para marco de lectura abierto peque?o.
|
|
KR20230043869A
(ko)
*
|
2020-08-07 |
2023-03-31 |
스페이스크래프트 세븐, 엘엘씨 |
Aav 벡터를 사용한 플라코필린-2(pkp2) 유전자 요법
|
|
KR20240032971A
(ko)
|
2021-07-08 |
2024-03-12 |
테나야 테라퓨틱스, 인코포레이티드 |
유전자 요법을 위한 최적화된 발현 카세트
|